These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 17205570)
21. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients. Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683 [TBL] [Abstract][Full Text] [Related]
22. Sensitization and sensitivity: defining the unsensitized patient. Gebel HM; Bray RA Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756 [TBL] [Abstract][Full Text] [Related]
23. High negative predictive value of an amplified flow cytometry crossmatch before living donor kidney transplantation. Lindemann M; Nyadu B; Heinemann FM; Kribben A; Paul A; Horn PA; Witzke O Hum Immunol; 2010 Aug; 71(8):771-6. PubMed ID: 20457201 [TBL] [Abstract][Full Text] [Related]
24. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of flow cytometric panel reactive antibody in renal transplant recipients - examination of 238 cases of renal transplantation. Ishida H; Tanabe K; Furusawa M; Ishizuka T; Hayashi T; Tokumoto T; Miyamoto N; Shirakawa H; Shimmura H; Shimizu T; Toma H Transpl Int; 2005 Feb; 18(2):163-8. PubMed ID: 15691268 [TBL] [Abstract][Full Text] [Related]
26. Clinical cytometry and progress in HLA antibody detection. Bray RA; Tarsitani C; Gebel HM; Lee JH Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808 [TBL] [Abstract][Full Text] [Related]
27. Crossmatch procedures used in organ transplantation. Gebel HM; Lebeck LK Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966 [TBL] [Abstract][Full Text] [Related]
28. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Vaidya S Transplantation; 2008 Apr; 85(7):1046-50. PubMed ID: 18408587 [TBL] [Abstract][Full Text] [Related]
29. The crossmatch may still be the most clinically relevant histocompatibility test performed. Kerman R; Lappin J; Kahan B; Katz S; McKissick E; Hosek K; Acorda N; Wooley N; Hoover A; Miller K; Rodriguez L; Moore B; Melcher P; Biedermann B; Van Buren C Clin Transpl; 2007; ():227-9. PubMed ID: 18642454 [TBL] [Abstract][Full Text] [Related]
30. Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization. Toyoda M; Pao A; Vo A; Lukovsky M; Radha R; Sado T; Ge S; Reinsmoen N; Chai NN; Baden L; Petrosyan A; Skinner E; Mirocha J; Jordan SC Transpl Immunol; 2010 Feb; 22(3-4):121-7. PubMed ID: 19944759 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength. Ellis TM; Schiller JJ; Roza AM; Cronin DC; Shames BD; Johnson CP Hum Immunol; 2012 Jul; 73(7):706-10. PubMed ID: 22537747 [TBL] [Abstract][Full Text] [Related]
32. Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible? Faenza A; Fuga G; Bertelli R; Scolari MP; Buscaroli A; Stefoni S Transplant Proc; 2008; 40(6):1833-8. PubMed ID: 18675064 [TBL] [Abstract][Full Text] [Related]
34. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107 [TBL] [Abstract][Full Text] [Related]
35. Positive pre-transplant flow-panel reactive antibody detected after accelerated acute rejection with negative pre-transplant flow crossmatch. Miura M; Kubota KC; Itoh T; Ono T; Morita K; Watarai Y; Harada H; Hirano T; Nonomura K Clin Transplant; 2006; 20 Suppl 15():33-7. PubMed ID: 16848873 [TBL] [Abstract][Full Text] [Related]
36. SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation. Tardif GN; McCalmon RT Clin Transplant; 1996 Dec; 10(6 Pt 2):594-7. PubMed ID: 8996748 [TBL] [Abstract][Full Text] [Related]
37. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases. Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594 [TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases. Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants. Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065 [TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach. Poli F; Cardillo M; Scalamogna M Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]